Pillar Pacific Capital Management’s Biogen BIIB Stock Holding History

Pillar Pacific Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$8.7M	Buy	31,082 +1,696	+6%	+$457K	0.67%	62
2020 Q4	$7.2M	Sell	29,386 -1,959	-6%	-$505K	0.6%	66
2020 Q3	$8.89M	Buy	31,345 +224	+0.7%	+$62.5K	0.85%	38
2020 Q2	$8.33M	Buy	31,121 +792	+3%	+$238K	0.88%	38
2020 Q1	$9.6M	Buy	30,329 +343	+1%	+$104K	1.26%	16
2019 Q4	$8.9M	Sell	29,986 -52	-0.2%	-$14.4K	0.91%	37
2019 Q3	$6.99M	Sell	30,038 -132	-0.4%	-$30.7K	0.79%	46
2019 Q2	$7.06M	Buy	30,170 +437	+1%	+$101K	0.79%	47
2019 Q1	$7.03M	Sell	29,733 -301	-1%	-$94.8K	0.81%	45
2018 Q4	$9.04M	Sell	30,034 -80	-0.3%	-$25.5K	1.19%	18
2018 Q3	$10.6M	Buy	30,114 +15	+0%	+$5.16K	1.15%	19
2018 Q2	$8.74M	Buy	30,099 +380	+1%	+$107K	1.01%	26
2018 Q1	$8.14M	Buy	29,719 +1,270	+4%	+$394K	0.97%	32
2017 Q4	$9.06M	Buy	28,449 +128	+0.5%	+$41.1K	1.1%	20
2017 Q3	$8.87M	Buy	28,321 +225	+0.8%	+$66.6K	1.14%	18
2017 Q2	$7.62M	Buy	28,096 +17	+0.1%	+$4.5K	1.04%	25
2017 Q1	$7.68M	Buy	28,079 +95	+0.3%	+$26.9K	1.09%	23
2016 Q4	$7.94M	Buy	27,984 +532	+2%	+$158K	1.22%	12
2016 Q3	$8.59M	Sell	27,452 -199	-0.7%	-$58.9K	1.35%	7
2016 Q2	$6.69M	Buy	27,651 +1,005	+4%	+$265K	1.13%	18
2016 Q1	$6.94M	Buy	26,646 +951	+4%	+$251K	1.2%	15
2015 Q4	$7.87M	Buy	25,695 +99	+0.4%	+$28.4K	1.41%	10
2015 Q3	$7.47M	Buy	25,596 +926	+4%	+$306K	1.4%	7
2015 Q2	$9.96M	Sell	24,670 -48	-0.2%	-$19.3K	1.72%	3
2015 Q1	$10.4M	Sell	24,718 -276	-1%	-$109K	1.83%	2
2014 Q4	$8.48M	Sell	24,994 -232	-0.9%	-$75.1K	1.53%	5
2014 Q3	$8.35M	Sell	25,226 -218	-0.9%	-$71.9K	1.53%	3
2014 Q2	$8.02M	Buy	25,444 +1,070	+4%	+$322K	1.5%	4
2014 Q1	$7.46M	Sell	24,374 -1,289	-5%	-$409K	1.51%	3
2013 Q4	$7.17M	Buy	25,663 +327	+1%	+$84.6K	1.43%	4
2013 Q3	$6.1M	Sell	25,336 -200	-0.8%	-$44.8K	1.35%	4
2013 Q2	$5.5M	Buy	+25,536	New	+$5.46M	1.31%	4

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pillar Pacific Capital Management's BIIB Position: Q1 2021 in Review

Pillar Pacific Capital Management increased its Biogen (BIIB) stake by 5.8% in Q1 2021, buying an estimated $457K and bringing the position to 31,082 shares worth $8.7M. The position accounts for 0.67% of the portfolio, ranked #62.

Pillar Pacific Capital Management first reported a position in BIIB in Q2 2013 and has held it in 32 quarters since. The position peaked at $10.6M in Q3 2018. 1,093 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

Pillar Pacific Capital Management held 31,082 shares of Biogen worth $8.7M as of Q1 2021.
Pillar Pacific Capital Management bought 1,696 Biogen shares in Q1 2021, an estimated $457K.
Biogen made up 0.67% of Pillar Pacific Capital Management's portfolio in Q1 2021, its #62 holding.
Pillar Pacific Capital Management first reported a position in Biogen in Q2 2013 and has held it in 32 quarters since.
Pillar Pacific Capital Management's Biogen position peaked at $10.6M in Q3 2018.
1,093 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Pillar Pacific Capital Management's 13F filing for Q1 2021, filed 4 May 2021.